202 related articles for article (PubMed ID: 24189640)
21. Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.
Park HK; Kim H; Kim HG; Cho YM; Jung WY; Han HS; Hwang TS; Kwon GY; Lim SD
J Korean Med Sci; 2015 May; 30(5):533-41. PubMed ID: 25931782
[TBL] [Abstract][Full Text] [Related]
22. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
23. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
[TBL] [Abstract][Full Text] [Related]
24. The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells.
Olokpa E; Bolden A; Stewart LV
J Cell Physiol; 2016 Dec; 231(12):2664-72. PubMed ID: 26945682
[TBL] [Abstract][Full Text] [Related]
25. Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer.
Segawa Y; Yoshimura R; Hase T; Nakatani T; Wada S; Kawahito Y; Kishimoto T; Sano H
Prostate; 2002 May; 51(2):108-16. PubMed ID: 11948965
[TBL] [Abstract][Full Text] [Related]
26. [Expressions and significances of CRABPII and E-FABP in non-small cell lung cancer].
Liu Q; Wang S; Xu H; Zhang S
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):12-9. PubMed ID: 23327868
[TBL] [Abstract][Full Text] [Related]
27. The developmental changes and effect on IMF content of H-FABP and PPARgamma mRNA expression in sheep muscle.
Huang ZG; Xiong L; Liu ZS; Qiao Y; Liu SR; Ren HX; Xie Z; Liu GQ; Li XB
Yi Chuan Xue Bao; 2006 Jun; 33(6):507-14. PubMed ID: 16800381
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
Cho SJ; Kook MC; Lee JH; Shin JY; Park J; Bae YK; Choi IJ; Ryu KW; Kim YW
Int J Cancer; 2015 Feb; 136(4):810-20. PubMed ID: 24976296
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Th17 differentiation by epidermal fatty acid-binding protein.
Li B; Reynolds JM; Stout RD; Bernlohr DA; Suttles J
J Immunol; 2009 Jun; 182(12):7625-33. PubMed ID: 19494286
[TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.
Nitschke K; Erben P; Waldbillig F; Abdelhadi A; Weis CA; Gottschalt M; Wahby S; Nuhn P; Boutros M; Michel MS; von Hardenberg J; Worst TS
World J Urol; 2020 Mar; 38(3):637-645. PubMed ID: 30701334
[TBL] [Abstract][Full Text] [Related]
31. PPARgamma and Wnt/beta-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations.
Jiang Y; Zou L; Zhang C; He S; Cheng C; Xu J; Lu W; Zhang Y; Zhang H; Wang D; Shen A
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1551-9. PubMed ID: 19495794
[TBL] [Abstract][Full Text] [Related]
32. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
[TBL] [Abstract][Full Text] [Related]
33. Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer.
Forootan SS; Wong YC; Dodson A; Wang X; Lin K; Smith PH; Foster CS; Ke Y
Hum Pathol; 2007 Sep; 38(9):1321-9. PubMed ID: 17599389
[TBL] [Abstract][Full Text] [Related]
34. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
[TBL] [Abstract][Full Text] [Related]
35. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
36. Ribosomal protein l19 is a prognostic marker for human prostate cancer.
Bee A; Ke Y; Forootan S; Lin K; Beesley C; Forrest SE; Foster CS
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2061-5. PubMed ID: 16609016
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
Blitek A; Szymanska M
Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
Kristiansen G; Jacob J; Buckendahl AC; Grützmann R; Alldinger I; Sipos B; Klöppel G; Bahra M; Langrehr JM; Neuhaus P; Dietel M; Pilarsky C
Clin Cancer Res; 2006 Nov; 12(21):6444-51. PubMed ID: 17085658
[TBL] [Abstract][Full Text] [Related]
39. N-3 PUFAs attenuate ischemia/reperfusion induced intestinal barrier injury by activating I-FABP-PPARγ pathway.
Wang X; Pan L; Lu J; Li N; Li J
Clin Nutr; 2012 Dec; 31(6):951-7. PubMed ID: 22554584
[TBL] [Abstract][Full Text] [Related]
40. Chicken adipocyte fatty acid-binding protein knockdown affects expression of peroxisome proliferator-activated receptor γ gene during oleate-induced adipocyte differentiation.
Shi H; Zhang Q; Wang Y; Yang P; Wang Q; Li H
Poult Sci; 2011 May; 90(5):1037-44. PubMed ID: 21489952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
